Date | Time | Source | Announcement |
---|---|---|---|
22 Apr 2003 | 04:47 PM | Capital Group | |
02 Apr 2003 | 03:51 PM | Exanta | |
01 Apr 2003 | 07:00 AM | Nexium | |
01 Apr 2003 | 07:00 AM | Purchase of Own Securities | |
31 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
26 Mar 2003 | 04:00 PM | Director Shareholding | |
13 Mar 2003 | 07:13 AM | Purchase of Own Securities | |
11 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
10 Mar 2003 | 07:00 AM | Crestor MRP Completion | |
10 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
07 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
05 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
03 Mar 2003 | 07:00 AM | Crestor in Europe | |
03 Mar 2003 | 07:00 AM | Purchase of Own Securities | |
27 Feb 2003 | 12:21 PM | Annual Report and Accounts | |
26 Feb 2003 | 07:00 AM | Purchase of Own Securities | |
19 Feb 2003 | 07:00 AM | Crestor | |
18 Feb 2003 | 07:00 AM | Research Update: AZD3582 | |
17 Feb 2003 | 07:00 AM | Exanta Sportif | |
13 Feb 2003 | 07:01 AM | Crestor | |
11 Feb 2003 | 09:00 AM | Iressa | |
30 Jan 2003 | 11:00 AM | Final Results (part 2 of 2) | |
30 Jan 2003 | 11:00 AM | Final Results (part 1 of 2) | |
29 Jan 2003 | 09:00 AM | Notice of Results | |
14 Jan 2003 | 04:00 PM | Capital Group | |
10 Jan 2003 | 03:00 PM | Capital Group | |
09 Jan 2003 | 03:00 PM | Update on Iressa | |
02 Jan 2003 | 01:30 PM | Seroquel | |
23 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
20 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
19 Dec 2002 | 07:09 AM | Casodex | |
19 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
16 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
13 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
12 Dec 2002 | 10:00 AM | Omeprazole Judgment | |
12 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
11 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
06 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
05 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
04 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
02 Dec 2002 | 07:00 AM | Purchase of Own Securities | |
29 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
28 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
27 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
26 Nov 2002 | 04:07 PM | Director Shareholding | |
26 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
25 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
22 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
21 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
18 Nov 2002 | 07:00 AM | Purchase of Own Securities |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.